Drugs like aspirin could reduce breast cancer and help existing sufferers

But they stress that further research is needed to determine the best type, dose and duration and whether the benefits of regularly using non-steroidal anti-inflammatory drugs (NSAIDs) outweigh the side effects, especially for high-risk groups.

“Our review of research published over the last 27 years suggests that, in addition to possible prevention, there may also be a role for NSAIDs in the treatment of women with established breast cancer” says Professor Ian Fentiman from the Hedley Atkins Breast Unit at the hospital, part of Guy's and St Thomas' NHS Foundation Trust.

“NSAID use could be combined with hormone therapy or used to relieve symptoms in the commonest cause of cancer-related deaths in women.”

Professor Fentiman and Mr Avi Agrawal reviewed 21 studies covering more than 37,000 women published between 1980 and 2007.

Their review included 11 studies of women with breast cancer and ten studies that compared women who did and did not have the disease.

“The purpose of a review like this is to look at a wide range of published studies and see if it is possible to pull together all the findings and come to any overarching conclusions” explains Professor Fentiman. “This includes looking at any conflicting results and exploring how the studies were carried out.

“For example some of the studies we looked at as part of this review found no links between NSAIDs and reduced levels of breast cancer, while others suggested that taking NSAIDs can reduce the breast cancer risk by about a fifth.

“Having weighed up the findings from over 20 studies, we have concluded that NSAIDs may well offer significant protection against developing breast cancer in the first place and may provide a useful addition to the treatment currently available to women who already have the disease.

“Recent studies of NSAIDs use have shown about a 20 per cent risk reduction in the incidence of breast cancer, but this benefit may be confined to aspirin use alone and not other NSAIDs.”

Previous studies have suggested that NSAIDs like aspirin and ibuprofen, which have traditionally been used as mainstream non-prescription analgesics, may provide protection against coronary heart disease and some malignancies, such as colorectal cancer.

But Professor Fentiman is urging caution until further research fully weighs up the pros and cons of using NSAIDs to prevent and treat breast cancer.

“Our review did not look at the potential side effects of using NSAIDs on a regular basis” stresses Professor Fentiman “These can include gastrointestinal bleeding and perforation which can carry a significant risk of ill health and death.

“It would be essential to take these negative effects into account before we could justify routinely using NSAIDs like aspirin to prevent breast cancer.

“More research is clearly needed and we are not advocating that women take these non prescription drugs routinely until the benefits and risks are clearer.

“But our findings clearly indicate that these popular over-the-counter drugs could, if used correctly, play an important role in preventing and treating breast cancer.”

Source: Blackwell Publishing

Daily aspirin may reduce risk of common type of breast cancer
Taking aspirin on a daily basis may lower women’s risk of a particular type of breast cancer, according to results published in BioMed Central’s open access journal Breast Cancer Research. In this large study, aspirin use was linked to a small reduction in estrogen receptor-positive breast cancers. However, unlike in some previous research, aspirin and related painkillers were not found to reduce the total risk of breast cancer.
Study takes a step toward better defining fatigue
In an effort to better define and ultimately address fatigue more effectively, a qualitative study from The University of Texas M. D. Anderson Cancer Center has identified three primary themes - loss of strength or energy, major effects of fatigue and associated sensations - among patients being treated with standard radiation therapy.
Connecting cancer genes
A large genetic study in mice has identified hundreds of genes involved in the development of cancer by examining the DNA of more than 500 lymphomas to find the cancer causing mutations.
Embryonic pathway delivers stem cell traits
Studies of how cancer cells spread have led to a surprising discovery about the creation of cells with adult stem cell characteristics, offering potentially major implications for regenerative medicine and for cancer treatment.
Girls, young women can cut risk of early breast cancer through regular exercise
Mothers, here’s another reason to encourage your daughters to be physically active: Girls and young women who exercise regularly between the ages of 12 and 35 have a substantially lower risk of breast cancer before menopause compared to those who are less active, new research shows.
Molecular 'clock' could predict risk for developing breast cancer
A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a woman’s risk for developing breast cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found.
Physical activity more likely to prevent breast cancer in certain groups
Physically active women are 25 per cent less likely to get breast cancer, but certain groups are more likely to see these benefits than others, finds a review of research published online ahead of print in the British Journal of Sports Medicine.
6-month follow-up diagnostic mammograms recommended for women with probably benign lesions
Radiologists can, with confidence, recommend a six-month follow-up diagnostic mammogram rather than an immediate biopsy for patients with “probably benign” breast lesions, a new study emphasizes.

Drugs like aspirin could reduce breast cancer and help existing sufferers

Related stories:

News discussion: